{"id":1067970,"date":"2020-11-13T00:51:25","date_gmt":"2020-11-13T05:51:25","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/exmceuticals-provides-bi-weekly-default-status-report\/"},"modified":"2024-08-18T11:41:29","modified_gmt":"2024-08-18T15:41:29","slug":"exmceuticals-provides-bi-weekly-default-status-report","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/exmceuticals-provides-bi-weekly-default-status-report.php","title":{"rendered":"EXMceuticals Provides Bi-Weekly Default Status Report"},"content":{"rendered":"<p><![CDATA[VANCOUVER, British Columbia, Nov.  12, 2020  (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the \u201cCompany\u201d or \u201cEXM\u201d) is providing this bi-weekly default status report in accordance with National Policy 12-203 Management Cease Trade Orders (\u201cNP 12-203\u201d). On October 23, 2020, the Company announced that, for reasons set out in its news release of October 23, 2020, the filing of its annual audited financial statements for the year ended June 30, 2020, the accompanying management\u2019s discussion and analysis and the related CEO and CFO certifications (collectively, the \u201cAnnual Filings\u201d) would not be filed by the prescribed deadline of October 28, 2020.]]><\/p>\n<p>Excerpt from:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/12\/2126108\/0\/en\/EXMceuticals-Provides-Bi-Weekly-Default-Status-Report.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"EXMceuticals Provides Bi-Weekly Default Status Report\">EXMceuticals Provides Bi-Weekly Default Status Report<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Excerpt from: EXMceuticals Provides Bi-Weekly Default Status Report <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/exmceuticals-provides-bi-weekly-default-status-report.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067970","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067970"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067970"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067970\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}